Therefore, we currently extend our experiments with anle138b to Abeta, tau, SOD1 and TDP43 aggregation important for AD, frontotemporal dementia (FTD), and amyotrophic lateral sclerosis (ALS). This evidence concerns the gene MAPT and Alzheimer disease.